Clinical Trial Update: Autologous Bronchial Basal Cell Transplantation for Treatment of COPD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous bronchial basal cell transplantation for chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Autologous bronchial basal cells transplant

Snippet

Sponsor: Regend Therapeutics | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: COMPLETED